A Survey of High Risk Patient and Caregiver Attitudes and Beliefs Regarding the Prescription of Intranasal Naloxone Spray for Opioid Overdose
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 182
- 试验地点
- 1
- 主要终点
- To determine the proportion of high risk patients who perceive receiving a prescription of intranasal naloxone to be beneficial for them
研究概览
简要总结
This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.
详细描述
PRIMARY OBJECTIVE:
I. To determine the proportion of high risk patients who perceive receiving a prescription of intranasal naloxone to be beneficial for them.
SECONDARY OBJECTIVES:
I. To determine the proportion of caregivers who perceive receiving a prescription of intranasal naloxone to be beneficial for the patient.
II. To determine the association between high risk patients' and their caregivers' characteristics (this includes cut-annoyed-guilty-eye [CAGE], screener and opioid assessment for patients with pain [SOAPP], age, gender, ethnicity, education, employment status, presence of caregiver, cancer type, cancer stage, reason for Narcan prescription, health insurance, and setting of Narcan prescription) and their perception that a prescription for intranasal naloxone is beneficial for patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients must have been prescribed intranasal naloxone in the past 1 year
- •Patients and caregivers must be able to understand, read, write, and speak English
- •Patients must have no clinical evidence of cognitive impairment, as determined by the palliative care provider (Memorial Delirium Assessment Scale score of >= 7)
- •Patients must sign an informed consent
- •Caregivers may sign an informed consent if available during the visit
- •Caregivers may verbally consent over the phone if not present during the visit
- •Caregiver must be a friend, significant other or family member
- •Caregivers must have no evidence of cognitive impairment, as determined based on orientation questions pertaining to the date, day of the week, time, and place
排除标准
- •PATIENT: Emotional or psychosocial distress as identified by the patient's palliative care
- •PATIENT: Participants with Edmonton Symptom Assessment System (ESAS) anxiety score of > 6
研究组 & 干预措施
Observational (survey)
Participants complete a survey over 30 minutes.
干预措施: Survey Administration (Other)
结局指标
主要结局
To determine the proportion of high risk patients who perceive receiving a prescription of intranasal naloxone to be beneficial for them
时间窗: Up to 1 year
次要结局
- To determine the proportion of caregivers who perceive receiving a prescription of intranasal naloxone to be beneficial for the patient.(Up to 1 year)
- To determine the association between high risk patients' and their caregivers' characteristics(Up to 1 year)